"From experience we know that working with exceptional partners, regardless of size, geography, or setting, will enhance Sanofi's capacity to break new ground on many disease fronts-including those most relevant to our recent collaborations that focus on multiple myeloma and other cancer treatments as well as autoimmune and inflammatory diseases."
John Reed, Head of Global R&D
